Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1993 Sep;70(3):211. doi: 10.1136/hrt.70.3.211

Muirhead's syndrome and medullipin. A new syndrome and a unique hypotensive agent.

J D Swales
PMCID: PMC1025296  PMID: 8398487

Full text

PDF

Page 211

211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Göthberg G., Lundin S., Folkow B., Thorén P. Suppression of tonic sympathetic nerve activity by depressor agents released from the declipped kidney. Acta Physiol Scand. 1982 Sep;116(1):93–95. doi: 10.1111/j.1748-1716.1982.tb10603.x. [DOI] [PubMed] [Google Scholar]
  2. Karlström G., Arnman V., Bergström G., Bohman S. O., Rudenstam J., Göthberg G. Do angiotensin converting enzyme inhibitors lower blood pressure in the rat partly via the humorally mediated antihypertensive system of the renal medulla? J Hypertens. 1990 Jun;8(6):501–513. doi: 10.1097/00004872-199006000-00002. [DOI] [PubMed] [Google Scholar]
  3. Muirhead E. E. An alternate road. Blood Press. 1992 Oct;1(3):132–134. doi: 10.3109/08037059209077507. [DOI] [PubMed] [Google Scholar]
  4. Muirhead E. E. Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture. Hypertension. 1980 Jul-Aug;2(4):444–464. doi: 10.1161/01.hyp.2.4.444. [DOI] [PubMed] [Google Scholar]
  5. Muirhead E. E., Byers L. W., Capdevila J., Brooks B., Pitcock J. A., Brown P. S. The renal antihypertensive endocrine function: its relation to cytochrome P-450. J Hypertens. 1989 May;7(5):361–369. doi: 10.1097/00004872-198905000-00003. [DOI] [PubMed] [Google Scholar]
  6. Muirhead E. E., Germain G., Leach B. E., Pitcock J. A., Stephenson P., Brooks B., Brosius W. L., Daniels E. G., Hinman J. W. Production of renomedullary prostaglandins by renomedullary interstitial cells grown in tissue culture. Circ Res. 1972 Sep;31(9 Suppl):161–172. [PubMed] [Google Scholar]
  7. Muirhead E. E., Streeten D. H., Brooks B., Schroeder E. T., Byers L. W. Persistent hypotension associated with hypermedullipinemia: a new syndrome. Blood Press. 1992 Oct;1(3):138–148. doi: 10.3109/08037059209077509. [DOI] [PubMed] [Google Scholar]
  8. Muirhead E. E., Streeten D. H., Byers L. W., Brooks B., Schroeder E. T. Lipomedullipinoma: a source of hypermedullipinemia. Blood Press. 1993 Sep;2(3):183–188. doi: 10.3109/08037059309077549. [DOI] [PubMed] [Google Scholar]
  9. Swales J. D., Bing R. F., Edmunds M. E., Russell G. I. Renal vasodepressor mechanism: characterization by chemical medullectomy. Am J Med Sci. 1988 Apr;295(4):241–245. doi: 10.1097/00000441-198804000-00004. [DOI] [PubMed] [Google Scholar]
  10. Swales J. D., Bing R. F., Edmunds M. E., Russell G. I., Thurston H. Reversal of renovascular hypertension: role of the renal medulla. Can J Physiol Pharmacol. 1987 Aug;65(8):1566–1571. doi: 10.1139/y87-246. [DOI] [PubMed] [Google Scholar]
  11. Taverner D., Bing R. F., Fletcher A., Russell G., Swales J. D., Thurston H. Hypertension produced by chemical renal medullectomy: evidence for a renomedullary vasodepressor function in the rat. Clin Sci (Lond) 1984 Nov;67(5):521–528. doi: 10.1042/cs0670521. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES